Difference between revisions of "Midkine"
| Line 51: | Line 51: | ||
|- | |- | ||
| Notes | | Notes | ||
| − | | | + | | It seems that Q42 and Q44 serve alternatively as glutamine donor substrates |
| + | |||
| + | It has enhanced activity upon crosslinking by TG2. | ||
| + | |||
|- | |- | ||
| {{infobox header}} | | | {{infobox header}} | | ||
Revision as of 13:14, 23 July 2007
| Template:Infobox header| Midkine | |
|---|---|
| Midkine | |
| Substrate peptide name | Midkine |
| Synonyms | - |
| Determination type | In vitro |
| Source | Homo sapiens |
| Subcellular localization | Extracellular, plasma |
| Swissprot ID | P21741 |
| Reactive glutamines | Q42, Q44, Q95 |
| Reactive lysines | K63 |
| Substrate sequence | GTCGAQTQRIRCR
NAQCQETIRV FGADCKYKFEN |
| Structure | 1MKN |
| Surface accessibility | ASAView pdf |
| Disorder prediction | IUPred |
| Reference | PMID:9083079 |
| Notes | It seems that Q42 and Q44 serve alternatively as glutamine donor substrates
It has enhanced activity upon crosslinking by TG2. |
| Template:Infobox header | | |
